Amanda C. Cano
Impact in
- Pharmaceutical Science top 0.2%
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
- Biological Psychiatry top 2%
Papers in
-
- Advanced Drug Delivery Systems 13
- Advancements in Transdermal Drug Delivery 13
- Physiology 29
- Alzheimer's disease research and treatments 25
- Co-authors
- Eliana B. Souto (42 shared papers)Elena Sánchez‐López (46 shared papers)Miren Ettcheto (45 shared papers)Antoni Camins (44 shared papers)Maria Luisa García (30 shared papers)Marta Espina (25 shared papers)Amélia Maria Silva (7 shared papers)Ana López-Machado (7 shared papers)
In The Last Decade
Amanda C. Cano
103 papers receiving 6.4k citations
Amanda C. Cano's Hit Papers
Peers
Comparison fields: 5 of 161
- Pharmaceutical Science 953
- Biological Psychiatry 184
- Biomaterials 839
- Neurology 488
- Physiology 1.1k
Countries citing papers authored by Amanda C. Cano
This map shows the geographic impact of Amanda C. Cano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amanda C. Cano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amanda C. Cano more than expected).
Fields of papers citing papers by Amanda C. Cano
This network shows the impact of papers produced by Amanda C. Cano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amanda C. Cano. The network helps show where Amanda C. Cano may publish in the future.
Co-authors
The 25 scholars most cited alongside Amanda C. Cano, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 109 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | New insights into the genetic etiology of Alzheimer’s disease and related dementias Hit paper breakdown → | 2022 | 1436 |
| 2 | Metal-Based Nanoparticles as Antimicrobial Agents: An Overview Hit paper breakdown → | 2020 | 1192 |
| 3 | Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's disease mice model Hit paper breakdown → | 2019 | 290 |
| 4 | 2018 | 242 | |
| 5 | Microemulsions and Nanoemulsions in Skin Drug Delivery Hit paper breakdown → | 2022 | 225 |
| 6 | 2019 | 221 | |
| 7 | 2022 | 171 | |
| 8 | 2019 | 164 | |
| 9 | 2016 | 130 | |
| 10 | 2020 | 114 | |
| 11 | 2021 | 109 | |
| 12 | 2021 | 99 | |
| 13 | 2018 | 84 | |
| 14 | 2021 | 82 | |
| 15 | 2019 | 71 | |
| 16 | 2020 | 70 | |
| 17 | 2021 | 66 | |
| 18 | 2019 | 65 | |
| 19 | 2020 | 65 | |
| 20 | 2021 | 61 |
About Amanda C. Cano
Amanda C. Cano is a scholar working on Pharmaceutical Science, Physiology, Neurology, Biological Psychiatry and Biomaterials, having authored 109 papers that have together received 6.5k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (25 papers), Advanced Drug Delivery Systems (13 papers), Advancements in Transdermal Drug Delivery (13 papers), Nanoparticle-Based Drug Delivery (10 papers), Dementia and Cognitive Impairment Research (8 papers), Neuroinflammation and Neurodegeneration Mechanisms (8 papers), Cholinesterase and Neurodegenerative Diseases (8 papers) and Tryptophan and brain disorders (7 papers). The work is most often cited by research in Pharmaceutical Science (953 citations), Biological Psychiatry (184 citations), Biomaterials (839 citations), Neurology (488 citations) and Physiology (1.1k citations). Amanda C. Cano has collaborated with scholars based in Spain, Portugal and Brazil. Frequent co-authors include Eliana B. Souto, Elena Sánchez‐López, Miren Ettcheto, Antoni Camins, Maria Luisa García, Marta Espina, Amélia Maria Silva, Ana López-Machado, Ruth Galindo and Gerard Esteruelas. Their work appears in journals such as International Journal of Molecular Sciences, Pharmaceutics, Alzheimer s Research & Therapy, Journal of Alzheimer s Disease and Biomedicine & Pharmacotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.